Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
US Pharmacists Add Cherry Syrup To Drug Content To Make Their Own Version For Kids Parents usually try to steer their children away from ingredients like sugar and artificial cherry flavoring. But this fall, those pedestrian food additives might help treat some children stricken with the flu. With the liquid …
In this paper, European food safety legislation is presented, and special attention is devoted to monitoring residues of veterinary drugs in foodstuffs of animal origin. After a short review of the state of the art of analytical methodology for antibiotic residue analysis, the paper focuses on validation of analytical methods, …
Buys US rights for Oscient Pharma's Antara. Pharmaceutical major Lupin has acquired the US rights for a cholesterol lowering drug, Antara (Fenofibrate capsules, 43 mg and 130 mg), from bankrupt US drug company Oscient Pharmaceuticals for close to $39 million (Rs 188 crore). The drug had $70 million (Rs 337.5 …
NATCO Pharma hopes to sell 10 million capsules of Natflu, the generic version of oseltamivir, the drug used to treat swine flu, by next month. The Hyderabad-based company has tied up with healthcare chain Medplus for distribution and is in talks with other distributors to ramp up its supply chain …
THE increasing population of higher-income group in the country will open a potential $ 8-billion market for multinational companies selling costly drugs, including patented products, by 2015, a Ficci-Ernst & Young study said. Besides, the report says the domestic pharmaceutical market is expected to touch $20 billion by 2015 from …
Sept. 18: Drug maker Natco Pharma on Friday said it has launched anti-swine flu drug Natflu. "Natco Pharma has launched Natflu capsule, the cure for swine flu," the Hyderabad-based firm said in a statement. The maximum retail price for the medicine is fixed at Rs 480 for a bottle of …
8 sites for human trials on 600 to 800 persons Three leading European manufacturers of Influenza-A H1N1 vaccine have agreed to conduct human trials in India to help the country procure vaccine shots for its high-risk populations. Following hectic negotiations on this front, Novartis, Baxter and GlaxoSmithKline recently conveyed their …
While H1N1 vaccine has got regulatory approval abroad, Indian vaccine manufacturers are likely to start animal testing by the end of this month. Dates were finalised after government gave Rs 10 crore each to three vaccine manufacturers
New Delhi: India has for the first time ever managed to foil a bio-piracy bid in a record three weeks time. Thanks to the recently created Traditional Knowledge Digital Library (TKDL), which has till now completed documenting over two lakh medical formulations of Ayurveda, Siddha and Unani to save them …
In Talks With GlaxoSmithKline, Pfizer & Novartis Mohit Bhalla ET NOW WOCKHARDT, a troubled drugmaker with huge debts, is in talks with GlaxoSmithKline, Pfizer and Novartis to sign a deal that would give marketing and research rights of its diabetes drugs under development to one of the global companies, two …
GLAXOSMITHKLINE (GSK) and Roche, the two original drugmakers of swine flu drugs, have said they have no immediate plans to launch their drugs in the Indian retail market as priority is to supply to governments globally. This leaves five Indian generic companies
Early data on the H1N1 vaccines show the vaccines to be highly effective with no adverse effects. Two peer-reviewed articles now published in the online first addition of new England Journal of medicine, which has the preliminary data of the monovalent H1N1 vaccine, have shown that the vaccines are working …
New Delhi: As H1N1 continues to claim lives, government on Monday gave the green signal for retail sale of Tamiflu. The Centre is paying around Rs 270 for 10 tablets to Hetero Drugs.
Khomba Singh NEW DELHI FROM Tuesday, the US Food and Drug Administration (FDA) will halve the grace period it extends to drug makers globally who are found wanting in maintaining production standards and fast track actions against violators and exoneration of those who take prompt corrective measures. India has the …
